DocSym
β
Searchsearch
Search
(L87.1) Reactive perforating collagenosis
More details coming soon
4 903 in individuals diagnosis reactive perforating collagenosis confirmed
Diagnosis reactive perforating collagenosis is diagnosed Men are 2.02% more likely than Women
2 501
Men receive the diagnosis reactive perforating collagenosis
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
2 402
Women receive the diagnosis reactive perforating collagenosis
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease reactive perforating collagenosis - Men aged 70-74 and Women aged 85-89
In Men diagnosis is most often set at age 35-39, 45-59, 65-74, 80-84
Less common in men the disease occurs at Age 0-34, 40-44, 60-64, 75-79, 85-95+Less common in women the disease occurs at Age 0-9, 15-19, 25-29, 35-39, 45-49, 55-59, 65-79, 90-95+
In Women diagnosis is most often set at age 10-14, 20-24, 30-34, 40-44, 50-54, 60-64, 80-89
Disease Features reactive perforating collagenosis
Absence or low individual and public risk
Reactive perforating collagenosis - what does this mean
Reactive perforating collagenosis is a rare skin disorder caused by an abnormal reaction of the body’s immune system to the collagen in the skin. it is characterized by the formation of small, firm bumps on the skin that can become ulcerated and may lead to scarring. the condition can affect any area of the body but is most common on the lower legs.
What happens during the disease - reactive perforating collagenosis
Reactive perforating collagenosis is a rare skin disorder that is thought to be caused by an abnormal response to trauma or injury. it is believed that the trauma triggers an abnormal immune response that leads to the formation of antibodies that attack the collagen in the skin. this leads to the formation of small papules that eventually rupture and release collagen into the dermis, causing an inflammatory response and the formation of new, abnormal collagen fibers.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination
- Skin biopsy
- Blood tests
- X-ray imaging
- Ultrasound imaging
- CT scan
- MRI scan
- Skin lesion sampling for culture and sensitivity
Treatment and Medical Assistance
Main goal: To reduce the symptoms of Reactive Perforating Collagenosis.
- Prescribe oral corticosteroids to reduce inflammation.
- Prescribe topical corticosteroids to reduce inflammation.
- Prescribe topical antibiotics to reduce the risk of infection.
- Prescribe systemic antibiotics to reduce the risk of infection.
- Prescribe antifungal medications to reduce the risk of infection.
- Prescribe phototherapy to reduce inflammation and promote healing.
- Prescribe immunosuppressants to reduce inflammation.
- Prescribe retinoids to reduce inflammation and promote healing.
- Prescribe laser therapy to reduce inflammation and promote healing.
- Prescribe topical retinoids to reduce inflammation and promote healing.
- Prescribe topical antiseptics to reduce the risk of infection.
- Prescribe topical emollients to reduce inflammation and promote healing.
- Prescribe topical moisturizers to reduce inflammation and promote healing.
- Prescribe topical anti-itch medications to reduce itching.
- Prescribe oral antihistamines to reduce itching.
- Prescribe topical anesthetics to reduce pain.
- Prescribe oral analgesics to reduce pain.
- Prescribe physical therapy to reduce pain and promote healing.
- Prescribe lifestyle modifications to reduce inflammation and promote healing.
18 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Reactive perforating collagenosis - Prevention
Reactive perforating collagenosis can be prevented by avoiding potential skin irritants such as soaps, detergents, and solvents, and by keeping skin hydrated and moisturized. sun protection is also important to prevent further skin damage. additionally, people with a history of skin problems should follow their doctor's advice and use recommended topical medications.